Centre Catalan D'Oncologie
Perpignan, France
Cancer treatment center in Perpignan
80 Rue Pascal Marie Agasse, 66000 Perpignan
About Centre Catalan D'Oncologie
"Nos médecins oncologues et radiologues vous accueillent de lundi au vendredi pour tous types de soins médicaux. Pour prendre un rendez-vous, contactez le secrétariat."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Intergroupe Francophone de Cancerologie Thoracique
3
UNICANCER
3
ARCAGY/ GINECO GROUP
2
AGO Research GmbH
1
Centre Francois Baclesse
1
Centre Hospitalier Annecy Genevois
1
Centre Hospitalier Intercommunal Creteil
1
Centre Leon Berard
1
Centre Oscar Lambret
1
Federation Francophone de Cancerologie Digestive
1
Clinical Trials at Centre Catalan D'Oncologie
During the past decade, Centre Catalan D'Oncologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer
2006-07-01
2014-01-01
Completed
242
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
2008-02-01
2014-09-01
Completed
820
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer
2009-09-01
2021-06-01
Completed
1,997
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
2010-03-01
2015-12-01
Completed
106
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
2010-06-17
2017-12-01
Completed
2,000
Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer
2010-12-27
2025-10-01
Active, not recruiting
1,006
Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments
2010-01-01
2014-07-01
Completed
490
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre Catalan D'Oncologie" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials
sponsored, "UNICANCER" with 3 trials sponsored, "ARCAGY/ GINECO GROUP" with 2 trials sponsored and "AGO Research GmbH"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Catalan D'Oncologie"
#1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Centre Catalan D'Oncologie
According to Clinical.Site data, the most researched conditions in "Centre Catalan D'Oncologie" are
"Breast Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Bone Metastases" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Centre Catalan D'Oncologie" in a lesser frequency.
Clinical Trials Intervention Types at Centre Catalan D'Oncologie
Most popular intervention types in "Centre Catalan D'Oncologie" are "Drug" (16 trials), "Radiation" (7 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Pemetrexed" (2 trials), "Trastuzumab" (2 trials), "Accelerated partial breast irradiation" (1 trials) and "Aromatase Inhibitors" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Catalan D'Oncologie
The vast majority of trials in "Centre Catalan D'Oncologie" are
18 trials for "All" genders and 8 trials for "Female" genders.
Clinical Trials Status at Centre Catalan D'Oncologie
Currently, there are NaN active trials in "Centre Catalan D'Oncologie".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Centre Catalan D'Oncologie,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Centre Catalan D'Oncologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".